| Title | Investigational New Drugs |
| Abbreviation | Investig. New Drugs |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2) |
| h-index | 100 |
| Overall Rank/Ranking | 4282 |
| SCImago Journal Rank (SJR) | 1.074 |
| Impact Score | 2.63 |
| Publisher | Springer |
| Country | United States |
| ISSN | 01676997, 15730646 |
| Best Quartile | Q1 |
| Coverage History | 1983-2025 |
The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.
Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor.
Investigational New Drugs is a journal covering the technologies/fields/categories related to Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2). It is published by Springer. The overall rank of Investigational New Drugs is 4282. According to SCImago Journal Rank (SJR), this journal is ranked 1.074. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 100. The best quartile for this journal is Q1.
The ISSN of Investigational New Drugs journal is 01676997, 15730646. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Investigational New Drugs is cited by a total of 1298 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Investigational New Drugs is 2.63, which is computed in 2025 as per its definition. Investigational New Drugs IF is decreased by a factor of 0.29 and approximate percentage change is -9.93% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Investigational New Drugs is 2.63. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.63 |
| 2023 | 2.92 |
| 2022 | 3.62 |
| 2021 | 3.89 |
| 2020 | 3.29 |
| 2019 | 3.52 |
| 2018 | 2.70 |
| 2017 | 3.69 |
| 2016 | 3.71 |
| 2015 | 3.71 |
| 2014 | 3.27 |
Investigational New Drugs has an h-index of 100. It means 100 articles of this journal have more than 100 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Investigational New Drugs is 01676997, 15730646. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Investigational New Drugs is 4282. According to SCImago Journal Rank (SJR), this journal is ranked 1.074. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.074 |
| 2023 | 1.086 |
| 2022 | 0.943 |
| 2021 | 0.965 |
| 2020 | 1.254 |
| 2019 | 1.493 |
| 2018 | 1.135 |
| 2017 | 1.573 |
| 2016 | 1.340 |
| 2015 | 1.388 |
| 2014 | 1.093 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4282 |
| 2023 | 3853 |
| 2022 | 4625 |
| 2021 | 4318 |
| 2020 | 3070 |
| 2019 | 2243 |
| 2018 | 3613 |
| 2017 | 2126 |
| 2016 | 2852 |
| 2015 | 2716 |
| 2014 | 3802 |
Investigational New Drugs is published by Springer. It's publishing house is located in United States. Coverage history of this journal is as following: 1983-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Investigational New Drugs is Investig. New Drugs. This abbreviation ('Investig. New Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Investigational New Drugs latest impact IF is 2.63. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.89 (2021) and 2.63 (2024), respectively, in the last 11 years. Moreover, its average IS is 3.36 in the previous 11 years.
The Investigational New Drugs has an SJR (SCImago Journal Rank) of 1.074, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.573 in 2017 and the lowest being 0.943 in 2022. Furthermore, the average SJR of the Investigational New Drugs over the previous 11-year period stands at 3.36.
The latest h-index of the Investigational New Drugs is 100.
The Investigational New Drugs is published by the Springer, with its country of publication being the United States.
The Investigational New Drugs is currently ranked 4282 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2126 in 2017 and its lowest position of 4625 in 2022.
The standard ISO4 abbreviation for the Investigational New Drugs is Investig. New Drugs.
Investigational New Drugs is classified as a journal that the Springer publishes.
The Investigational New Drugs encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Investigational New Drugs is assigned the following International Standard Serial Numbers (ISSN): 01676997, 15730646.
The best quartile for the Investigational New Drugs is Q1 (2024).
The Investigational New Drugs coverage history can be summarized as follows: 1983-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of International Financial Management and Accounting | journal | 1434 | Wiley-Blackwell Publishing Ltd | 50 | 10.53 |
| Journal of Supply Chain Management | journal | 331 | Wiley-Blackwell | 119 | 9.76 |
| International Journal of Mathematical Education in Science and Technology | journal | 6477 | Taylor and Francis Ltd. | 45 | 1.82 |
| International Journal of Applied Linguistics | journal | 6655 | Wiley-Blackwell Publishing Ltd | 57 | 2.61 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10600 | Schweizerbart Science Publishers | 18 | 4.25 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 1553 | Association for Computing Machinery | 111 | 7.47 |
| Acta Periodica Technologica | journal | 22883 | University of Novi Sad, Faculty of Technology | 22 | 0.71 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.63 |
| 2023 | 2.92 |
| 2022 | 3.62 |
| 2021 | 3.89 |
| 2020 | 3.29 |
| 2019 | 3.52 |
| 2018 | 2.70 |
| 2017 | 3.69 |
| 2016 | 3.71 |
| 2015 | 3.71 |
| 2014 | 3.27 |
